Tyra Biosciences, Inc. (TYRA)

NMS – Real Time Price. Currency in USD

25.48

+0.30 (1.19%)

Market open: Aug 12, 2026, 10:09 AM EDT

25.68

+0.50 (1.99%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-546K

-519K

-353K

-296K

Gross Profit

-546K

-519K

-353K

-296K

Operating expenses (excl. COGS)

-132M

-104M

-80M

-59M

Operating Income

-133M

-104M

-80M

-59M

Non-operating income, total

13M

18M

11M

Pretax income

-120M

-86M

-69M

-55M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-120M

-86M

-69M

-55M

Discontinued operations

Net income

-120M

-86M

-69M

-55M

Dilution adjustment

Preferred dividends

Tyra Biosciences, Inc. (TYRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tyra Biosciences, Inc. (TYRA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Tyra Biosciences, Inc. (TYRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tyra Biosciences, Inc. (TYRA)

Income Statement (Annual)

Income Statement (Annual)